Literature DB >> 7578176

Incidence of phrenic neuropathy after isolated lung transplantation. The Loyola University Lung Transplant Group.

P H Sheridan1, A Cheriyan, J Doud, S E Dornseif, A Montoya, J Houck, M E Flisak, J M Walsh, E R Garrity.   

Abstract

BACKGROUND: Isolated lung transplantation is a viable therapeutic option for many patients with end-stage pulmonary disease. Other intrathoracic surgical procedures have a well documented incidence of phrenic nerve dysfunction, although the incidence after lung transplantation has not been studied.
METHODS: Thirty-one patients who underwent lung transplantation were evaluated for evidence of phrenic nerve dysfunction and subsequent recovery. Risk factors contributing to the incidence of injury were examined. Phrenic nerve injury was defined by two separate diagnostic tests (Transcutaneous Phrenic Nerve Conduction Studies and Fluoroscopic evaluation of diaphragmatic movement) used in combination.
RESULTS: Of the 27 patients who were completely evaluated after the operation, eight had defining criteria for nerve injury--an incidence of 29.6%. Of those affected, the majority of injuries (89%) resulted in complete paralysis of the affected hemidiaphragm. The highest incidence of injury occurred in patients who underwent bilateral single lung transplantation (41%), with the right phrenic nerve being injured most often (78%). Fortunately, no significant postoperative morbidity was attributable to the occurrence of phrenic nerve injury when compared with those patients who did not sustain injury.
CONCLUSIONS: The analysis of possible risk factors resulted in the hypothesis that the likely mechanism of injury in these patients was due to stretching or direct instrumentation of the nerve, and thus measures should be instituted to minimize the possibility of injury.

Entities:  

Mesh:

Year:  1995        PMID: 7578176

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

Review 1.  Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease.

Authors:  Namrata Patel; Malcolm DeCamp; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

2.  Pediatric lung transplantation.

Authors:  Charles B Huddleston
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-02

3.  Atrial Fibrillation After Lung Transplantation: Incidence, Predictors and Long-Term Implications.

Authors:  Santiago Garcia; Mariana Canoniero; Srinivasan Sattiraju; Lin Y Chen; Wayne Adkisson; Marshall Hertz; David G Benditt
Journal:  J Atr Fibrillation       Date:  2011-09-30

4.  An assessment of the distance between the phrenic nerve and major intrathoracic structures.

Authors:  Tim Bishop; Derek Clark; Heather Bendyk; Joey Bell; David Jaynes
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

5.  Chronic postsurgical pain: still a neglected topic?

Authors:  Igor Kissin; Simon Gelman
Journal:  J Pain Res       Date:  2012-11-05       Impact factor: 3.133

Review 6.  Diaphragm Dysfunction: Diagnostic Approaches and Management Strategies.

Authors:  Bruno-Pierre Dubé; Martin Dres
Journal:  J Clin Med       Date:  2016-12-05       Impact factor: 4.241

Review 7.  Diaphragmatic Palsy.

Authors:  Laxmi Kokatnur; Mohan Rudrappa
Journal:  Diseases       Date:  2018-02-13

8.  Influence of early neurological complications on clinical outcome following lung transplant.

Authors:  Josep Gamez; Maria Salvado; Alejandro Martinez-de La Ossa; Maria Deu; Laura Romero; Antonio Roman; Judith Sacanell; Cesar Laborda; Isabel Rochera; Miriam Nadal; Francesc Carmona; Estevo Santamarina; Nuria Raguer; Merce Canela; Joan Solé
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

9.  Diaphragm electromyography guidance for a lung transplant recipient with difficult weaning from mechanical ventilation: A case report.

Authors:  Yuanda Xu; Qi Qing; Minyong Liang; Weibo Liang; Zhimin Lin; Weiliang Wu; Weiqun He; Xiaoqing Liu; Yuanming Luo; Yimin Li; Jianxing He
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.